+1-800-267-5763
Presented by Lesya Shuba, MD, PhD, FRCSC
This module will consist of interactive discussion of clinical cases, allowing participants to discuss some challenging clinical scenarios in glaucoma. Participants will have a chance to review common features of glaucoma as opposed to other optic neuropathies, discuss unusual cases of inflammatory glaucoma, the diagnostic and therapeutic dilemmas of glaucoma in high myopic individuals, and the challenges of dealing with pseudo-exfoliative glaucoma, among others. The clinical cases presented in this module were selected to generate discussion, with several particularities of the cases highlighting the “beyond the evidence” general theme for this program, where no clear right or wrong answer exists.
LEARNING OBJECTIVES
At the end of this session, participants will be able to:
- Discuss the differential diagnosis of optic neuropathy
- Review inflammatory glaucomas and how to correctly diagnose and treat them
- Discuss pearls and pitfalls of OCT imaging in glaucoma
- Management of pseudo-exfoliative glaucoma
- Discuss clues and management for conditions masquerading as glaucoma
Program Schedule
6:30 PM: Hors d’oeuvres
7:00 PM: Presentation
To RSVP, please contact:
Peter Anderson
[email protected]
902-229-8848
RSVP Deadline: Thursday, November 8, 2018
CPD CREDITS
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Ophthalmological Society. Physicians may claim a maximum of 1.5 Section 1 credits.
Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 credits. Information on the process to convert Royal College MOC credit to AMA credit.
Physicians should only claim credit commensurate with the extent of their participation in the learning activity.
INSIGHT was co-developed with Allergan and was planned to achieve scientific integrity, objectivity, and balance. The use of the partner logo is ethically permissible.
More information on the INSIGHT Glaucoma Program
